Rx (Prescription Medicine)
Original price was: USD $ 30.00.USD $ 17.00Current price is: USD $ 17.00.
You save USD $ 13.00 (43%)
USD $ 0.57 per tablet
Duovir N Tablet are manufactured by Cipla in India. Each Bottle pack includes Pack of 30 Tablets, making Duovir N Tablet an effective option for HIV. Prescription Required from your healthcare provider to purchase Duovir N Tablet Indogenmed deals in all type of generic Lamivudine, Zidovudine and Nevirapine.
| Brand Name | |
|---|---|
| Country Of Origin | India |
| Medicine Form | Tablet |
| Medicine Type | Generic |
| Molecule | |
| Packaging Type | Bottle |
| Pack Quantity | 30 Tablets |
| Rx Status | Rx (Prescription Medicine) |
| Strength | 150 Mg, 200 Mg, 300 mg |
Only logged in customers who have purchased this product may leave a review.
Price range: USD $ 28.00 through USD $ 149.00
Original price was: USD $ 469.00.USD $ 450.00Current price is: USD $ 450.00.
Price range: USD $ 45.00 through USD $ 246.00
Original price was: USD $ 290.00.USD $ 280.00Current price is: USD $ 280.00.
Other brands of Lamivudine, Nevirapine, Zidovudine 150 Mg — the same active ingredient at the same strength, from a different manufacturer.
Exact match
Nevimune 200 Mg Tablets
Original price was: USD $ 34.56.USD $ 27.65Current price is: USD $ 27.65.
USD $ 2.77 per unit
Exact match
Vonaday Tablets
USD $ 110.00
USD $ 3.67 per unit
Exact match
Viropil Tablets
Original price was: USD $ 110.00.USD $ 90.00Current price is: USD $ 90.00.
USD $ 3.00 per unit
Exact match
Avonza Tablet
Original price was: USD $ 68.00.USD $ 55.00Current price is: USD $ 55.00.
USD $ 1.83 per unit
Medically reviewed by
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
Reviews
There are no reviews yet.